Skip to main content

letter

. 1996 Aug 17;313(7054):423. doi: 10.1136/bmj.313.7054.423

Ecstasy and neurodegeneration. Advice is that "less is more".

PMCID: PMC2351827 PMID: 8761238

423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Green A. R., Goodwin G. M. Ecstasy and neurodegeneration. BMJ. 1996 Jun 15;312(7045):1493–1494. doi: 10.1136/bmj.312.7045.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
Greer G., Tolbert R. Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs. 1986 Oct-Dec;18(4):319–327. doi: 10.1080/02791072.1986.10472364. [DOI] [PubMed] [Google Scholar]
Peroutka S. J., Newman H., Harris H. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology. 1988 Dec;1(4):273–277. [PubMed] [Google Scholar]
Solowij N., Hall W., Lee N. Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. Br J Addict. 1992 Aug;87(8):1161–1172. doi: 10.1111/j.1360-0443.1992.tb02003.x. [DOI] [PubMed] [Google Scholar]
Winstock A. R. Chronic paranoid psychosis after misuse of MDMA. BMJ. 1991 May 11;302(6785):1150–1151. doi: 10.1136/bmj.302.6785.1150-b. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES